Neovacs S.A. (ALNEV) — Financial Flexibility Index
Neovacs S.A. (ALNEV) has a Financial Flexibility Index of -0.63x as of December 2025. Free cash flow of €-2.60 Million (operating CF €-2.60 Million minus capex €1.18K) represents -1% of total liabilities (€4.10 Million). Explore how much does Neovacs S.A. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Neovacs S.A. Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Neovacs S.A. across 19 annual periods. Check ALNEV capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Financial Flexibility Index for Neovacs S.A. (2007–2025)
Year-by-year free cash flow to debt coverage for Neovacs S.A.. For the full cash flow conversion analysis, see Neovacs S.A. cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.23x | €-5.03 Million | €-5.03 Million | €4.10 Million | ▼ -39.5% |
| 2024 | -0.88x | €-3.52 Million | €-3.60 Million | €4.01 Million | ▼ -90.7% |
| 2023 | -0.46x | €-1.71 Million | €-1.91 Million | €3.71 Million | ▲ +45.8% |
| 2022 | -0.85x | €-4.30 Million | €-4.45 Million | €5.05 Million | ▲ +58.6% |
| 2021 | -2.05x | €-9.56 Million | €-9.91 Million | €4.65 Million | ▲ +5.4% |
| 2020 | -2.17x | €-5.44 Million | €-5.65 Million | €2.50 Million | ▼ -28.8% |
| 2019 | -1.69x | €-8.10 Million | €-8.10 Million | €4.80 Million | ▲ +39.1% |
| 2018 | -2.77x | €-13.30 Million | €-13.31 Million | €4.80 Million | ▼ -112.1% |
| 2017 | -1.31x | €-14.13 Million | €-14.26 Million | €10.82 Million | ▲ +3.1% |
| 2016 | -1.35x | €-10.88 Million | €-11.00 Million | €8.08 Million | ▲ +9.0% |
| 2015 | -1.48x | €-7.67 Million | €-7.69 Million | €5.18 Million | ▲ +35.7% |
| 2014 | -2.30x | €-8.03 Million | €-8.05 Million | €3.49 Million | ▼ -38.4% |
| 2013 | -1.66x | €-6.97 Million | €-7.00 Million | €4.19 Million | ▲ +31.9% |
| 2012 | -2.44x | €-6.33 Million | €-6.33 Million | €2.59 Million | ▲ +31.1% |
| 2011 | -3.55x | €-8.56 Million | €-8.63 Million | €2.41 Million | ▼ -6.4% |
| 2010 | -3.33x | €-8.01 Million | €-8.10 Million | €2.40 Million | ▼ -105.2% |
| 2009 | -1.62x | €-7.92 Million | €-7.95 Million | €4.88 Million | ▲ +20.2% |
| 2008 | -2.04x | €-4.46 Million | €-4.49 Million | €2.19 Million | ▲ +3.5% |
| 2007 | -2.11x | €-4.29 Million | €-4.32 Million | €2.04 Million | — |